Indeed, melatonin supplementation improved antioxidant defense in MS through upregulation of catalase, manganese superoxide dismutase (MnSOD), and sirtuin 1 (SIRT1), an inhibitor of oxidative stress [146]. Here, SOD2 is linked to myeloid sarcoma.